Literature DB >> 15978105

The plasma hemostatic proteome: thrombin generation in healthy individuals.

K Brummel-Ziedins1, C Y Vossen, F R Rosendaal, K Umezaki, K G Mann.   

Abstract

BACKGROUND AND OBJECTIVES: The range of plasma concentrations of hemostatic analytes in the population is wide. In this study these components of blood coagulation phenotype are integrated in an attempt to predict clinical risk.
METHODS: We modeled tissue factor (TF)-induced thrombin generation in the control population (N = 473) from the Leiden Thrombophilia Study utilizing a numerical simulation model. Hypothetical thrombin generation curves were established by modeling pro- and anticoagulant factor levels for each individual. These curves were evaluated using parameters which describe the initiation, propagation and termination phases of thrombin generation, i.e. time to 10 nm thrombin (approximate clot time), total thrombin and the maximum rates and levels of thrombin generated. RESULTS AND
CONCLUSIONS: The time to 10 nm thrombin varied over a 3-fold range (2.9-9.5 min), maximum levels varied over a approximately 4-fold range (200-800 nm), maximum rates varied approximately 4.8-fold (90-435 nm min(-1)) and total thrombin varied approximately 4.5-fold (39-177 microm s(-1)) within this control population. Thrombin generation curves, defined by the clotting factor concentrations, were distinguished by sex, age, alcohol consumption, body mass index (BMI) and oral contraceptive (OC) use (OC > sex > BMI > age). Our results show that the capacity for thrombin generation in response to a TF challenge may represent a method to identify an individual's propensity for developing thrombosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15978105      PMCID: PMC1414093          DOI: 10.1111/j.1538-7836.2005.01249.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  60 in total

1.  Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives.

Authors:  J Rosing; G Tans; G A Nicolaes; M C Thomassen; R van Oerle; P M van der Ploeg; P Heijnen; K Hamulyak; H C Hemker
Journal:  Br J Haematol       Date:  1997-04       Impact factor: 6.998

2.  Blood clotting in minimally altered whole blood.

Authors:  M D Rand; J B Lock; C van't Veer; D P Gaffney; K G Mann
Journal:  Blood       Date:  1996-11-01       Impact factor: 22.113

3.  A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis.

Authors:  S R Poort; F R Rosendaal; P H Reitsma; R M Bertina
Journal:  Blood       Date:  1996-11-15       Impact factor: 22.113

Review 4.  The Leiden Thrombophilia Study (LETS).

Authors:  F J van der Meer; T Koster; J P Vandenbroucke; E Briët; F R Rosendaal
Journal:  Thromb Haemost       Date:  1997-07       Impact factor: 5.249

5.  A model for the tissue factor pathway to thrombin. II. A mathematical simulation.

Authors:  K C Jones; K G Mann
Journal:  J Biol Chem       Date:  1994-09-16       Impact factor: 5.157

6.  Molecular mechanism for familial protein C deficiency and thrombosis in protein CVermont (Glu20-->Ala and Val34-->Met).

Authors:  D Lu; E G Bovill; G L Long
Journal:  J Biol Chem       Date:  1994-11-18       Impact factor: 5.157

7.  A model for the tissue factor pathway to thrombin. I. An empirical study.

Authors:  J H Lawson; M Kalafatis; S Stram; K G Mann
Journal:  J Biol Chem       Date:  1994-09-16       Impact factor: 5.157

8.  Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms--the Leiden Thrombophilia Study (LETS).

Authors:  T Koster; F R Rosendaal; P H Reitsma; P A van der Velden; E Briët; J P Vandenbroucke
Journal:  Thromb Haemost       Date:  1994-06       Impact factor: 5.249

9.  Continuous registration of thrombin generation in plasma, its use for the determination of the thrombin potential.

Authors:  H C Hemker; S Wielders; H Kessels; S Béguin
Journal:  Thromb Haemost       Date:  1993-10-18       Impact factor: 5.249

10.  Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis.

Authors:  T Koster; A D Blann; E Briët; J P Vandenbroucke; F R Rosendaal
Journal:  Lancet       Date:  1995-01-21       Impact factor: 79.321

View more
  33 in total

1.  Is there value in kinetic modeling of thrombin generation? Yes.

Authors:  K G Mann
Journal:  J Thromb Haemost       Date:  2012-08       Impact factor: 5.824

2.  Mathematical and biological models of blood coagulation.

Authors:  T Orfeo; K G Mann
Journal:  J Thromb Haemost       Date:  2005-11       Impact factor: 5.824

3.  The impact of uncertainty in a blood coagulation model.

Authors:  Christopher M Danforth; Thomas Orfeo; Kenneth G Mann; Kathleen E Brummel-Ziedins; Stephen J Everse
Journal:  Math Med Biol       Date:  2009-05-18       Impact factor: 1.854

4.  Blood coagulation dynamics in haemostasis.

Authors:  K G Mann; T Orfeo; S Butenas; A Undas; K Brummel-Ziedins
Journal:  Hamostaseologie       Date:  2009-01       Impact factor: 1.778

5.  Mathematical model of thrombin generation and bleeding phenotype in Amish carriers of Factor IX:C deficiency vs. controls.

Authors:  S Gupta; M C Bravo; M Heiman; C Nakar; K Brummel-Ziedins; C H Miller; A Shapiro
Journal:  Thromb Res       Date:  2019-08-08       Impact factor: 3.944

6.  Dynamics of Thrombin Generation and Flux from Clots during Whole Human Blood Flow over Collagen/Tissue Factor Surfaces.

Authors:  Shu Zhu; Yichen Lu; Talid Sinno; Scott L Diamond
Journal:  J Biol Chem       Date:  2016-09-07       Impact factor: 5.157

7.  Cellular regulation of blood coagulation: a model for venous stasis.

Authors:  James E Campbell; Kathleen E Brummel-Ziedins; Saulius Butenas; Kenneth G Mann
Journal:  Blood       Date:  2010-09-23       Impact factor: 22.113

Review 8.  Modeling thrombin generation: plasma composition based approach.

Authors:  Kathleen E Brummel-Ziedins; Stephen J Everse; Kenneth G Mann; Thomas Orfeo
Journal:  J Thromb Thrombolysis       Date:  2014-01       Impact factor: 2.300

9.  The effect of high circulating estradiol levels on thrombin generation during in vitro fertilization.

Authors:  Kathleen E Brummel-Ziedins; Matthew Gissel; Charles Francis; John Queenan; Kenneth G Mann
Journal:  Thromb Res       Date:  2009-03-17       Impact factor: 3.944

Review 10.  Empirical and theoretical phenotypic discrimination.

Authors:  K E Brummel-Ziedins; T Orfeo; F R Rosendaal; A Undas; G E Rivard; S Butenas; K G Mann
Journal:  J Thromb Haemost       Date:  2009-07       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.